Pflügers Archiv - European Journal of Physiology

, Volume 457, Issue 3, pp 609–622 | Cite as

The gastric HK-ATPase: structure, function, and inhibition

  • Jai Moo Shin
  • Keith Munson
  • Olga Vagin
  • George Sachs
Ion Channels, Receptors and Transporters


The gastric H,K-ATPase, a member of the P2-type ATPase family, is the integral membrane protein responsible for gastric acid secretion. It is an α,β-heterodimeric enzyme that exchanges cytoplasmic hydronium with extracellular potassium. The catalytic α subunit has ten transmembrane segments with a cluster of intramembranal carboxylic amino acids located in the middle of the transmembrane segments TM4, TM5,TM6, and TM8. Comparison to the known structure of the SERCA pump, mutagenesis, and molecular modeling has identified these as constituents of the ion binding domain. The β subunit has one transmembrane segment with N terminus in cytoplasmic region. The extracellular domain of the β subunit contains six or seven N-linked glycosylation sites. N-glycosylation is important for the enzyme assembly, maturation, and sorting. The enzyme pumps acid by a series of conformational changes from an E1 (ion site in) to an E2 (ion site out) configuration following binding of MgATP and phosphorylation. Several experimental observations support the hypothesis that expulsion of the proton at 160 mM (pH 0.8) results from movement of lysine 791 into the ion binding site in the E2P configuration. Potassium access from the lumen depends on activation of a K and Cl conductance via a KCNQ1/KCNE2 complex and Clic6. K movement through the luminal channel in E2P is proposed to displace the lysine along with dephosphorylation to return the enzyme to the E1 configuration. This enzyme is inhibited by the unique proton pump inhibitor class of drug, allowing therapy of acid-related diseases.


The gastric H,K-ATPase ATPase structure–function Proton pump inhibitors Acid pump antagonists Gastric acid secretion 


  1. 1.
    Abe K, Kaya S, Taniguchi K, Hayashi Y, Imagawa T, Kikumoto M, Oiwa K, Sakaguchi K (2005) Evidence for a relationship between activity and the tetraprotomeric assembly of solubilized pig gastric H/K-ATPase. J Biochem (Tokyo) 138:293–301Google Scholar
  2. 2.
    Andersson K, Carlsson E (2005) Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases. Pharmacol Ther 108:294–307PubMedCrossRefGoogle Scholar
  3. 3.
    Asano S, Yoshida A, Yashiro H, Kobayashi Y, Morisato A, Ogawa H, Takeguchi N, Morii M (2004) The cavity structure for docking the K(+)-competitive inhibitors in the gastric proton pump. J Biol Chem 279:13968–13975PubMedCrossRefGoogle Scholar
  4. 4.
    Bamberg K, Mercier F, Reuben MA, Kobayashi Y, Munson KB, Sachs G (1992) cDNA cloning and membrane topology of the rabbit gastric H+/K(+)-ATPase alpha-subunit. Biochim Biophys Acta 1131:69–77PubMedGoogle Scholar
  5. 5.
    Besancon M, Shin JM, Mercier F, Munson K, Miller M, Hersey S, Sachs G (1993) Membrane topology and omeprazole labeling of the gastric H+,K(+)-adenosinetriphosphatase. Biochemistry 32:2345–2355PubMedCrossRefGoogle Scholar
  6. 6.
    Black JW, Duncan WAM, Durant CJ, Ganellin CR, Parsons ME (1972) Definition and antagonism of histamine H2 receptors. Nature 236:385–390PubMedCrossRefGoogle Scholar
  7. 7.
    Burnay M, Crambert G, Kharoubi-Hess S, Geering K, Horisberger JD (2003) Electrogenicity of Na,K- and H,K-ATPase activity and presence of a positively charged amino acid in the fifth transmembrane segment. J Biol Chem 278:19237–19244PubMedCrossRefGoogle Scholar
  8. 8.
    Codina J, Li J, Dubose TD Jr (2004) A carboxy-terminus motif of HKalpha2 is necessary for assembly and function. Kidney Int 66:2283–2292PubMedCrossRefGoogle Scholar
  9. 9.
    Dammann HG, Burkhardt F (1999) Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion. Eur J Gastroenterol Hepatol 11:1277–1282PubMedCrossRefGoogle Scholar
  10. 10.
    Dempski RE, Hartung K, Friedrich T, Bamberg E (2006) Fluorometric measurements of intermolecular distances between the alpha- and beta-subunits of the Na+/K+-ATPase. J Biol Chem 281:36338–36346PubMedCrossRefGoogle Scholar
  11. 11.
    Fellenius E, Berglindh T, Sachs G, Olbe L, Elander B, Sjostrand SE, Wallmark B (1981) Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase. Nature 290:159–161PubMedCrossRefGoogle Scholar
  12. 12.
    Ferron GM, McKeand W, Mayer PR (2001) Pharmacodynamic modeling of pantoprazole’s irreversible effect on gastric acid secretion in humans and rats. J Clin Pharmacol 41:149–156PubMedCrossRefGoogle Scholar
  13. 13.
    Forte JG, Forte TM, Black JA, Okamoto C, Wolosin JM (1983) Correlation of parietal cell structure and function. J Clin Gastroenterol 5(Suppl 1):17–27PubMedCrossRefGoogle Scholar
  14. 14.
    Galmiche JP, Bruley Des Varannes S, Ducrotte P, Sacher-Huvelin S, Vavasseur F, Taccoen A, Fiorentini P, Homerin M (2004) Tenatoprazole, a novel proton pump inhibitor with a prolonged plasma half-life: effects on intragastric pH and comparison with esomeprazole in healthy volunteers. Aliment Pharmacol Ther 19:655–662PubMedCrossRefGoogle Scholar
  15. 15.
    Gedda K, Scott D, Besancon M, Lorentzon P, Sachs G (1995) Turnover of the gastric H+,K(+)-adenosine triphosphatase alpha subunit and its effect on inhibition of rat gastric acid secretion. Gastroenterology 109:1134–1141PubMedCrossRefGoogle Scholar
  16. 16.
    Grishin AV, Caplan MJ (1998) ATP1AL1, a member of the non-gastric H,K-ATPase family, functions as a sodium pump. J Biol Chem 273:27772–27778PubMedCrossRefGoogle Scholar
  17. 17.
    Han KS, Kim YG, Yoo JK, Lee JW, Lee MG (1998) Pharmacokinetics of a new reversible proton pump inhibitor, YH1885, after intravenous and oral administrations to rats and dogs: hepatic first-pass effect in rats. Biopharm Drug Dispos 19:493–500PubMedCrossRefGoogle Scholar
  18. 18.
    Hersey SJ, Steiner L, Mendlein J, Rabon E, Sachs G (1988) SCH28080 prevents omeprazole inhibition of the gastric H+/K+-ATPase. Biochim Biophys Acta 956:49–57PubMedCrossRefGoogle Scholar
  19. 19.
    Im WB, Blakeman DP, Davis JP (1985) Irreversible inactivation of rat gastric (H+–K+)-ATPase in vivo by omeprazole. Biochem Biophys Res Commun 126:78–82PubMedCrossRefGoogle Scholar
  20. 20.
    Ito K, Kinoshita K, Tomizawa A, Inaba F, Morikawa-Inomata Y, Makino M, Tabata K, Shibakawa N (2007) Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526). J Pharmacol Exp Ther 323:308–317PubMedCrossRefGoogle Scholar
  21. 21.
    Kahrilas PJ, Dent J, Lauritsen K, Malfertheiner P, Denison H, Franzen S, Hasselgren G (2007) A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis. Clin Gastroenterol Hepatol 5:1385–1391PubMedCrossRefGoogle Scholar
  22. 22.
    Kaminski JJ, Bristol JA, Puchalski C, Lovey RG, Elliott AJ, Guzik H, Solomon DM, Conn DJ, Domalski MS, Wong SC, Gold EH, Long JF, Chiu PJ, Steinberg M, McPhail AT (1985) Antiulcer agents. 1. Gastric antisecretory and cytoprotective properties of substituted imidazo[1,2-a]pyridines. J Med Chem 28:876–892PubMedCrossRefGoogle Scholar
  23. 23.
    Katashima M, Yamamoto K, Tokuma Y, Hata T, Sawada Y, Iga T (1998) Comparative pharmacokinetic/pharmacodynamic analysis of proton pump inhibitors omeprazole, lansoprazole and pantoprazole, in humans. Eur J Drug Metab Pharmacokinet 23:19–26PubMedCrossRefGoogle Scholar
  24. 24.
    Kirchhoff P, Andersson K, Socrates T, Sidani S, Kosiek O, Geibel JP (2006) Characteristics of the K+-competitive H+,K+-ATPase inhibitor AZD0865 in isolated rat gastric glands. Am J Physiol Gastrointest Liver Physiol 291:G838–G843PubMedCrossRefGoogle Scholar
  25. 25.
    Lambrecht NW, Yakubov I, Scott D, Sachs G (2005) Identification of the K efflux channel coupled to the gastric H–K-ATPase during acid secretion. Physiol Genomics 21:81–91PubMedCrossRefGoogle Scholar
  26. 26.
    Maeda M, Ishizaki J, Futai M (1988) cDNA cloning and sequence determination of pig gastric (H+ + K+)-ATPase. Biochem Biophys Res Commun 157:203–209PubMedCrossRefGoogle Scholar
  27. 27.
    Maeda M, Oshiman K, Tamura S, Futai M (1990) Human gastric (H+ + K+)-ATPase gene. Similarity to (Na+ + K+)-ATPase genes in exon/intron organization but difference in control region. J Biol Chem 265:9027–9032PubMedGoogle Scholar
  28. 28.
    Melle-Milovanovic D, Milovanovic M, Nagpal S, Sachs G, Shin JM (1998) Regions of association between the alpha and the beta subunit of the gastric H,K-ATPase. J Biol Chem 273:11075–11081PubMedCrossRefGoogle Scholar
  29. 29.
    Mizukawa Y, Nishizawa T, Nagao T, Kitamura K, Urushidani T (2002) Cellular distribution of parchorin, a chloride intracellular channel-related protein, in various tissues. Am J Physiol Cell Physiol 282:C786–C795PubMedGoogle Scholar
  30. 30.
    Morth JP, Pedersen BP, Toustrup-Jensen MS, Sorensen TL, Petersen J, Andersen JP, Vilsen B, Nissen P (2007) Crystal structure of the sodium-potassium pump. Nature 450:1043–1049PubMedCrossRefGoogle Scholar
  31. 31.
    Munson KB, Gutierrez C, Balaji VN, Ramnarayan K, Sachs G (1991) Identification of an extracytoplasmic region of H+,K(+)-ATPase labeled by a K(+)-competitive photoaffinity inhibitor. J Biol Chem 266:18976–18988PubMedGoogle Scholar
  32. 32.
    Munson K, Vagin O, Sachs G, Karlish S (2003) Molecular modeling of SCH28080 binding to the gastric H,K-ATPase and MgATP interactions with SERCA- and Na,K-ATPases. Ann N Y Acad Sci 986:106–110PubMedCrossRefGoogle Scholar
  33. 33.
    Munson K, Garcia R, Sachs G (2005) Inhibitor and ion binding sites on the gastric H,K-ATPase. Biochemistry 44:5267–5284PubMedCrossRefGoogle Scholar
  34. 34.
    Munson K, Law RJ, Sachs G (2007) Analysis of the gastric H,K ATPase for ion pathways and inhibitor binding sites. Biochemistry 46:5398–5417PubMedCrossRefGoogle Scholar
  35. 35.
    Olesen C, Picard M, Winther AM, Gyrup C, Morth JP, Oxvig C, Moller JV, Nissen P (2007) The structural basis of calcium transport by the calcium pump. Nature 450:1036–1042PubMedCrossRefGoogle Scholar
  36. 36.
    Purhonen P, Thomsen K, Maunsbach AB, Hebert H (2006) Association of renal Na,K-ATPase alpha-subunit with the beta- and gamma-subunits based on cryoelectron microscopy. J Membr Biol 214:139–146PubMedCrossRefGoogle Scholar
  37. 37.
    Rabon EC, McFall TL, Sachs G (1982) The gastric [H,K]ATPase:H+/ATP stoichiometry. J Biol Chem 257:6296–6299PubMedGoogle Scholar
  38. 38.
    Reenstra WW, Forte JG (1981) H+/ATP stoichiometry for the gastric (K+ + H+)-ATPase. J Membr Biol 61:55–60PubMedCrossRefGoogle Scholar
  39. 39.
    Reenstra WW, Crothers J Jr, Forte JG (2007) The conformation of H,K-ATPase determines the nucleoside triphosphate (NTP) selectivity for active proton transport. Biochemistry 46:10145–10152PubMedCrossRefGoogle Scholar
  40. 40.
    Reuben MA, Lasater LS, Sachs G (1990) Characterization of a beta subunit of the gastric H+/K(+)-transporting ATPase. Proc Natl Acad Sci U S A 87:6767–6771PubMedCrossRefGoogle Scholar
  41. 41.
    Sachs G, Chang HH, Rabon E, Schackman R, Lewin M, Saccomani G (1976) A nonelectrogenic H+ pump in plasma membranes of hog stomach. J Biol Chem 251:7690–7698PubMedGoogle Scholar
  42. 42.
    Sachs G, Shin JM, Besancon M, Prinz C (1993) The continuing development of gastric acid pump inhibitors. Aliment Pharmacol Ther 7:4–12; discussion 29-31PubMedCrossRefGoogle Scholar
  43. 43.
    Sachs G, Shin JM, Howden CW (2006) Review article: the clinical pharmacology of proton pump inhibitors. Aliment Pharmacol Ther 23(Suppl 2):2–8PubMedCrossRefGoogle Scholar
  44. 44.
    Sachs G, Shin JM, Vagin O, Lambrecht N, Yakubov I, Munson K (2007) The gastric H,K ATPase as a drug target: past, present, and future. J Clin Gastroenterol 41:S226–S242PubMedCrossRefGoogle Scholar
  45. 45.
    Sawaguchi A, Aoyama F, Ide S, Suganuma T (2005) The cryofixation of isolated rat gastric mucosa provides new insights into the functional transformation of gastric parietal cells: an in vitro experimental model study. Arch Histol Cytol 68:151–160PubMedCrossRefGoogle Scholar
  46. 46.
    Shin JM, Sachs G (1994) Identification of a region of the H,K-ATPase alpha subunit associated with the beta subunit. J Biol Chem 269:8642–8646PubMedGoogle Scholar
  47. 47.
    Shin JM, Sachs G (2002) Restoration of acid secretion following treatment with proton pump inhibitors. Gastroenterology 123:1588–1597PubMedCrossRefGoogle Scholar
  48. 48.
    Shin JM, Sachs G (2004) Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo. Biochem Pharmacol 68:2117–2127PubMedCrossRefGoogle Scholar
  49. 49.
    Shin JM, Besancon M, Simon A, Sachs G (1993) The site of action of pantoprazole in the gastric H+/K(+)-ATPase. Biochim Biophys Acta 1148:223–233PubMedCrossRefGoogle Scholar
  50. 50.
    Shin JM, Cho YM, Sachs G (2004) Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors. J Am Chem Soc 126:7800–7811PubMedCrossRefGoogle Scholar
  51. 51.
    Shin JM, Grundler G, Senn-Bilfinger J, Simon WA, Sachs G (2005) Functional consequences of the oligomeric form of the membrane-bound gastric H,K-ATPase. Biochemistry 44:16321–16332PubMedCrossRefGoogle Scholar
  52. 52.
    Shin JM, Homerin M, Domagala F, Ficheux H, Sachs G (2006) Characterization of the inhibitory activity of tenatoprazole on the gastric H+,K+-ATPase in vitro and in vivo. Biochem Pharmacol 71:837–849PubMedCrossRefGoogle Scholar
  53. 53.
    Shull GE (1990) cDNA cloning of the beta-subunit of the rat gastric H,K-ATPase. J Biol Chem 265:12123–12126PubMedGoogle Scholar
  54. 54.
    Shull GE, Lingrel JB (1986) Molecular cloning of the rat stomach (H+ + K+)-ATPase. J Biol Chem 261:16788–16791PubMedGoogle Scholar
  55. 55.
    Simon WA, Herrmann M, Klein T, Shin JM, Huber R, Senn-Bilfinger J, Postius S (2007) Soraprazan: setting new standards in inhibition of gastric acid secretion. J Pharmacol Exp Ther 321:866–874PubMedCrossRefGoogle Scholar
  56. 56.
    Skrabanja AT, Asty P, Soumarmon A, Joep J, de Pont HH, Lewin MJ (1986) H+ transport by reconstituted gastric (H+ + K+)-ATPase. Biochim Biophys Acta 860:131–136PubMedCrossRefGoogle Scholar
  57. 57.
    Song I, Mortell MP, Gantz I, Brown DR, Yamada T (1993) Molecular cloning and structural analysis of canine gastric H+,K(+)-ATPase. Biochem Biophys Res Commun 196:1240–1247PubMedCrossRefGoogle Scholar
  58. 58.
    Swarts HG, Koenderink JB, Willems PH, Krieger E, De Pont JJ (2005) Asn792 participates in the hydrogen bond network around the K+-binding pocket of gastric H,K-ATPase. J Biol Chem 280:11488–11494PubMedCrossRefGoogle Scholar
  59. 59.
    Sweadner KJ, Donnet C (2001) Structural similarities of Na,K-ATPase and SERCA, the Ca(2+)-ATPase of the sarcoplasmic reticulum. Biochem J 356:685–704PubMedCrossRefGoogle Scholar
  60. 60.
    Toh BH, Gleeson PA, Simpson RJ, Moritz RL, Callaghan JM, Goldkorn I, Jones CM, Martinelli TM, Mu FT, Humphris DC et al (1990) The 60- to 90-kDa parietal cell autoantigen associated with autoimmune gastritis is a beta subunit of the gastric H+/K(+)-ATPase (proton pump). Proc Natl Acad Sci U S A 87:6418–6422PubMedCrossRefGoogle Scholar
  61. 61.
    Toyoshima C, Nakasako M, Nomura H, Ogawa H (2000) Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 A resolution. Nature 405:647–655PubMedCrossRefGoogle Scholar
  62. 62.
    Toyoshima C, Asahi M, Sugita Y, Khanna R, Tsuda T, MacLennan DH (2003) Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase. Proc Natl Acad Sci U S A 100:467–472PubMedCrossRefGoogle Scholar
  63. 63.
    Toyoshima C, Nomura H, Sugita Y (2003) Crystal structures of Ca2+-ATPase in various physiological states. Ann N Y Acad Sci 986:1–8PubMedCrossRefGoogle Scholar
  64. 64.
    Vagin O, Munson K, Lambrecht N, Karlish SJ, Sachs G (2001) Mutational analysis of the K+-competitive inhibitor site of gastric H,K-ATPase. Biochemistry 40:7480–7490PubMedCrossRefGoogle Scholar
  65. 65.
    Vagin O, Denevich S, Munson K, Sachs G (2002) SCH28080, a K+-competitive inhibitor of the gastric H,K-ATPase, binds near the M5-6 luminal loop, preventing K+ access to the ion binding domain. Biochemistry 41:12755–12762PubMedCrossRefGoogle Scholar
  66. 66.
    Vagin O, Denevich S, Sachs G (2003) Plasma membrane delivery of the gastric H,K-ATPase: the role of beta-subunit glycosylation. Am J Physiol Cell Physiol 285:C968–C976PubMedGoogle Scholar
  67. 67.
    Vagin O, Turdikulova S, Sachs G (2004) The H,K-ATPase beta subunit as a model to study the role of N-glycosylation in membrane trafficking and apical sorting. J Biol Chem 279:39026–39034PubMedCrossRefGoogle Scholar
  68. 68.
    Vagin O, Turdikulova S, Yakubov I, Sachs G (2005) Use of the H,K-ATPase beta subunit to identify multiple sorting pathways for plasma membrane delivery in polarized cells. J Biol Chem 280:14741–14754PubMedCrossRefGoogle Scholar
  69. 69.
    Wallmark B, Sachs G, Mardh S, Fellenius E (1983) Inhibition of gastric (H+ + K+)-ATPase by the substituted benzimidazole, picoprazole. Biochim Biophys Acta 728:31–38PubMedCrossRefGoogle Scholar
  70. 70.
    Wallmark B, Larsson H, Humble L (1985) The relationship between gastric acid secretion and gastric H+,K+-ATPase activity. J Biol Chem 260:13681–13684PubMedGoogle Scholar
  71. 71.
    Wallmark B, Briving C, Fryklund J, Munson K, Jackson R, Mendlein J, Rabon E, Sachs G (1987) Inhibition of gastric H+,K+-ATPase and acid secretion by SCH 28080, a substituted pyridyl(1,2a)imidazole. J Biol Chem 262:2077–2084PubMedGoogle Scholar
  72. 72.
    Wolosin JM, Forte JG (1985) K+ and Cl conductances in the apical membrane from secreting oxyntic cells are concurrently inhibited by divalent cations. J Membr Biol 83:261–272PubMedCrossRefGoogle Scholar
  73. 73.
    Yu KS, Bae KS, Shon JH, Cho JY, Yi SY, Chung JY, Lim HS, Jang IJ, Shin SG, Song KS, Moon BS (2004) Pharmacokinetic and pharmacodynamic evaluation of a novel proton pump inhibitor, YH1885, in healthy volunteers. J Clin Pharmacol 44:73–82PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Jai Moo Shin
    • 1
  • Keith Munson
    • 1
  • Olga Vagin
    • 1
  • George Sachs
    • 1
    • 2
  1. 1.Department of Physiology, David Geffen School of MedicineUniversity of California at Los Angeles and VA Greater Los Angeles Healthcare SystemLos AngelesUSA
  2. 2.George SachsMembrane BiologyLos AngelesUSA

Personalised recommendations